Medicare is launching a new pilot program that will require prior approval for 17 health services using artificial intelligence tools. The Wasteful and Inappropriate Service Reduction (WISeR) model is ...

AI-powered bug hunting has changed the calculus of what makes for an effective bounty program by accelerating vulnerability discovery — and subjecting code maintainers to ballooning volumes of AI flaw ...

Recursion, Roche, and its Genentech subsidiary have unveiled the latest product of their nearly four-year artificial intelligence (AI) drug discovery collaboration, a whole-genome map of specialized ...

Keep Windows 10 secure with updates after 2025 by enrolling in the Extended Security Updates program. When you purchase through links on our site, we may earn an affiliate commission. Here’s how it ...

A pilot program in six states will use a tactic employed by private insurers that has been heavily criticized for delaying and denying medical care. By Reed Abelson and Teddy Rosenbluth Like millions ...

Every time Grace publishes a story, you’ll get an alert straight to your inbox! Enter your email By clicking “Sign up”, you agree to receive emails from ...

Written in Rust, the PyApp utility wraps up Python programs into self-contained click-to-run executables. It might be the easiest Python packager yet. Every developer knows how hard it is to ...

Starting in January, Medicare will test out an artificial intelligence (AI) pilot program to decide whether patients get certain procedures covered or not. The Centers for Medicare & Medicaid Services ...

The Python Software Foundation warned users this week that threat actors are trying to steal their credentials in phishing attacks using a fake Python Package Index (PyPI) website. PyPI is a ...

A pandemic-era program aimed to facilitate hotel and office to affordable housing conversions. After a slow start, and numerous financing and design challenges, its first project is opening in Queens.

In a recent social media post, Peter Ray, senior director of medicinal chemistry at Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX), drew attention to a new article in WIRED from Veronique Greenwood ...